Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
The approval was driven by data from the Phase III TULIP-SC trial
Gazyva/Gazyvaro outperformed placebo across all key and secondary endpoints
Primary membranous nephropathy is a chronic autoimmune disease that attacks the kidneys’ filtering units
A final decision on the updated application is expected in the first half of 2026, while intravenous (IV) Saphnelo remains commercially available
The therapy was well tolerated through Week 24, with a safety profile consistent with Alumis’ Phase 2 data
SLE remains a life-threatening autoimmune disease, with patients facing an elevated risk of early mortality and long-term organ damage
CLE, a common form of lupus erythematosus, primarily causes diverse skin lesions
The study is being conducted under a USFDA IND, has received U.S. Fast Track Designation for SLE-ITP, and has obtained IND approval from China’s Center for Drug Evaluation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
